M&A Deal Summary |
|
|---|---|
| Date | 2021-07-06 |
| Target | Vetex Medical |
| Sector | Life Science |
| Buyer(s) | SurModics |
| Deal Type | Add-on Acquisition |
| Deal Value | 40M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1979 |
| Sector | Medical Products |
| Revenue | 133M USD (2023) |
SurModics provides surface modification coating technologies and in vitro diagnostic (IVD) products to the healthcare industry. Its two core businesses include: Medical Device Coatings – lubricious hydrophilic coatings, hemocompatible hydrophilic coatings, and advanced drug delivery systems; and In Vitro Diagnostics (IVD) – immunoassay reagents that improve the performance of in vitro diagnostic tests as well as custom coatings and stabilization products for Molecular Diagnostic applications. Surmodics was founded in 1979 and is based in Eden Prairie, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Life Science M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 5 of 5 |
| Country: Ireland M&A | 2 of 2 |
| Year: 2021 M&A | 1 of 1 |
| Size (of disclosed) | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-11 |
NorMedix
Plymouth, Minnesota, United States NorMedix, Inc. is a medical device design and development company. |
Buy | $14M |
